← Back to Search

Functional Mapping

Intracranial Stimulation Mapping for Epilepsy

N/A

Recruiting

Led By Alexander Herman, MD

Research Sponsored by University of Minnesota

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately after stimulation sessions

Awards & highlights

Study Summary

This trial will help researchers learn more about how epilepsy affects the brain, which could lead to better treatments for the condition.

Who is the study for?

This trial is for adults over 18 with epilepsy who are already getting intracranial EEG monitoring at the University of Minnesota/MINCEP program. They must understand the study, agree to all procedures, and be available throughout. Pregnant individuals or those unable to make independent decisions due to cognitive impairments are excluded.Check my eligibility

What is being tested?

The study is testing a new way to create brain maps in adult patients with partial epilepsy. These maps aim to pinpoint where in the brain seizures start and how different regions communicate during a seizure.See study design

What are the potential side effects?

Since this trial involves functional mapping during an already planned EEG monitoring procedure, side effects may include typical risks associated with EEG such as discomfort at electrode sites but specific side effects will depend on individual patient conditions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediately after stimulation sessions

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediately after stimulation sessions

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after stimulation sessions for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Electrical Stimulation of the Brain

Trial Design

1Treatment groups

Experimental Treatment

Group I: Research IESMExperimental Treatment1 Intervention

Functional mapping for research application

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor

1,381 Previous Clinical Trials

1,588,945 Total Patients Enrolled

12 Trials studying Epilepsy

501 Patients Enrolled for Epilepsy

Alexander Herman, MDPrincipal InvestigatorUMN

Media Library

Intracranial Stimulation Mapping (Functional Mapping) Clinical Trial Eligibility Overview. Trial Name: NCT05290610 — N/A

Epilepsy Research Study Groups: Research IESM

Epilepsy Clinical Trial 2023: Intracranial Stimulation Mapping Highlights & Side Effects. Trial Name: NCT05290610 — N/A

Intracranial Stimulation Mapping (Functional Mapping) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05290610 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are currently registered for this clinical research?

"Indeed, the information on clinicaltrials.gov states that this trial is in current pursuit of participants. It was initially published on June 1st 2022 and the most recent update occurred October 19th 2022. The study requires 30 individuals to take part, all at one site."

Answered by AI

Is it possible to still register for this trial?

"Clinicaltrials.gov indicates that this clinical trial is actively recruiting participants, with the initial posting dated June 1st 2022 and subsequent updates made on October 19th of the same year."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Intracranial Stimulation Mapping In Epilepsy

2022. "Intracranial Stimulation Mapping In Epilepsy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05290610.

All > Lgs Foundation > Epilepsy